Clinical Trial Update: The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether oral niacinamide lowers serum phosphorus in hemodialysis patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Niacinamide (nicotinamide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hyperphosphatemia | Phase 1 | Status: COMPLETED